Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

ludc webb

Harry Björkbacka

Researcher

ludc webb

Low Levels of CD4+CD28null T Cells at Baseline Are Associated With First-Time Coronary Events in a Prospective Population-Based Case-Control Cohort

Author

  • Lukas Tomas
  • Eva Bengtsson
  • Linda Andersson
  • Wiaam Badn
  • Christoffer Tengryd
  • Ana Persson
  • Andreas Edsfeldt
  • Peter M Nilsson
  • Alexandru Schiopu
  • Jan Nilsson
  • Isabel Gonçalves
  • Harry Björkbacka

Summary, in English

OBJECTIVE: CD4+CD28null T cells have been shown to be associated with recurrent coronary events and suggested as potential biomarker and therapeutic target. It is unknown whether CD4+CD28null T cells associate with first-time cardiovascular events. We examined CD4+CD28null T cells in a prospective population-based cohort and in patients with advanced atherosclerosis. Approach and Results: CD4+CD28null T cells were quantified in 272 individuals experiencing a first-time coronary event during up to 17 years of follow-up and 272 age- and sex-matched controls in a case-control study, nested within the population-based Malmö Diet and Cancer study. The highest tertile of CD4+CD28null T cells was associated with a lower incidence of first-time coronary events compared with the lowest tertile (odds ratio, 0.48 [95% CI, 0.29-0.79], P=0.004) when adjusting for Framingham risk factors. This association remained significant for events recorded after >9 years of follow-up, when most coronary events occurred, but not during the first 9 years of follow-up, despite similar odds ratio. Additionally, we analyzed CD4+CD28null T cells in 201 patients with advanced atherosclerosis undergoing carotid endarterectomy. The adjusted hazard ratio for cardiovascular events in patients with advanced atherosclerosis was 2.11 (95% CI, 1.10-4.05, P=0.024), comparing the highest with the lowest CD4+CD28null T-cell tertile.

CONCLUSIONS: Our findings reveal complex associations between CD4+CD28null T cells and cardiovascular disease. Although we confirm the reported positive associations with an adverse prognosis in patients with already established disease, the opposite associations with first-time coronary events in the population-based cohort may limit the clinical use of CD4+CD28null T cells.

Department/s

  • Cardiovascular Research - Cellular Metabolism and Inflammation
  • Cardiovascular Research - Immunity and Atherosclerosis
  • EXODIAB: Excellence in Diabetes Research in Sweden
  • Cardiovascular Research - Matrix and Inflammation in Atherosclerosis
  • Cardiovascular Research - Translational Studies
  • Internal Medicine - Epidemiology
  • EpiHealth: Epidemiology for Health
  • Hepato-Pancreato-Biliary Surgery
  • Surgery (Lund)

Publishing year

2020-02

Language

English

Pages

426-436

Publication/Series

Arteriosclerosis, Thrombosis, and Vascular Biology

Volume

40

Issue

2

Document type

Journal article

Publisher

Lippincott Williams & Wilkins

Topic

  • Cardiac and Cardiovascular Systems

Keywords

  • Atherosclerosis/blood
  • CD28 Antigens/immunology
  • CD4-Positive T-Lymphocytes/immunology
  • Case-Control Studies
  • Coronary Artery Disease/blood
  • Coronary Vessels/diagnostic imaging
  • Female
  • Flow Cytometry
  • Follow-Up Studies
  • Forecasting
  • Humans
  • Incidence
  • Lymphocyte Count
  • Male
  • Middle Aged
  • Population Surveillance
  • Prospective Studies
  • Sweden/epidemiology
  • T-Lymphocytes/immunology

Status

Published

Research group

  • Cardiovascular Research - Cellular Metabolism and Inflammation
  • Cardiovascular Research - Immunity and Atherosclerosis
  • Cardiovascular Research - Matrix and Inflammation in Atherosclerosis
  • Cardiovascular Research - Translational Studies
  • Internal Medicine - Epidemiology
  • Hepato-Pancreato-Biliary Surgery

ISBN/ISSN/Other

  • ISSN: 1524-4636